UnitedHealth Group Incorporated (UNH) is a Medical - Healthcare Plans company in the Healthcare sector, currently trading at $314.19. It has a SharesGrow Score of 58/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of UNH = $902.20 (+187.2% from the current price, the stock appears undervalued). Analyst consensus target is UNH = $385 (+22.7% upside).
Valuation: UNH trades at a trailing Price-to-Earnings (P/E) of 23.1 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.8.
Financials: revenue is $447.6B, +11.6%/yr average growth. Net income is $12.1B, growing at -13.6%/yr. Net profit margin is 2.7% (thin). Gross margin is 18.5% (-5.6 pp trend).
Balance sheet: total debt is $78.4B against $94.1B equity (Debt-to-Equity (D/E) ratio 0.83, moderate). Current ratio is 0.79 (tight liquidity). Debt-to-assets is 25.3%. Total assets: $309.6B.
Analyst outlook: 41 / 52 analysts rate UNH as buy (79%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 66/100 (Pass), Growth 48/100 (Partial), Past 100/100 (Pass), Health 33/100 (Fail), Moat 51/100 (Partial), Future 79/100 (Pass), Income 30/100 (Fail).
